We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTES icon
501
NetEase
NTES
$84.9B
$540K 0.04%
3,927
-2,215
-36% -$314K
CORT icon
502
Corcept Therapeutics
CORT
$12.3B
$538K 0.04%
+15,466
New +$1.21M
ITT icon
503
ITT
ITT
$19B
$535K 0.04%
3,085
+1,539
+100% +$276K
EME icon
504
Emcor
EME
$36.1B
$534K 0.04%
873
-65
-7% -$42.1K
RTX icon
505
RTX Corp
RTX
$302B
$533K 0.04%
+2,904
New +$504K
ALK icon
506
Alaska Air
ALK
$5.29B
$531K 0.04%
10,565
-20,289
-66% -$938K
MRCY icon
507
Mercury Systems
MRCY
$6.5B
$531K 0.04%
+7,276
New +$541K
MRK icon
508
Merck
MRK
$322B
$529K 0.04%
5,023
-5,515
-52% -$518K
IWM icon
509
iShares Russell 2000 ETF
IWM
$81.4B
$528K 0.04%
2,145
-9,774
-82% -$2.4M
IMRX icon
510
Immuneering
IMRX
$294M
$526K 0.04%
80,000
+7,533
+10% +$48.4K
SW
511
Smurfit Westrock
SW
$24.8B
$526K 0.04%
+13,602
New +$519K
LHX icon
512
L3Harris
LHX
$54.2B
$525K 0.04%
+1,789
New +$517K
ZTS icon
513
Zoetis
ZTS
$30.7B
$525K 0.04%
4,169
+2,135
+105% +$278K
TXT icon
514
Textron
TXT
$15.3B
$523K 0.04%
6,002
+2,229
+59% +$187K
NRP icon
515
Natural Resource Partners
NRP
$1.4B
$522K 0.04%
+5,000
New +$522K
LNG icon
516
Cheniere Energy
LNG
$55B
$517K 0.04%
2,659
-323
-11% -$67.8K
CCRN
517
DELISTED
Cross Country Healthcare
CCRN
$516K 0.04%
63,732
-50,024
-44% -$547K
MDT icon
518
Medtronic
MDT
$114B
$514K 0.04%
+5,352
New +$520K
NPAC
519
New Providence Acquisition Corp III
NPAC
$400M
$513K 0.04%
+50,000
New +$513K
IT icon
520
Gartner
IT
$12.2B
$512K 0.04%
+2,030
New +$489K
NU icon
521
Nu Holdings
NU
$67.4B
$511K 0.04%
30,501
+3,363
+12% +$54K
ZTO icon
522
ZTO Express
ZTO
$18.2B
$510K 0.04%
+24,400
New +$483K
NOW icon
523
ServiceNow
NOW
$132B
$507K 0.04%
3,311
+316
+11% +$54.2K
UNF icon
524
Unifirst Corp
UNF
$5.23B
$506K 0.04%
+2,622
New +$442K
FIP icon
525
FTAI Infrastructure
FIP
$518M
$506K 0.04%
109,691
+56,691
+107% +$279K

Similar funds

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.